Takeda UK has announced that the National Institute for Health and Care Excellence (NICE) has recommended Adcetris ...

Patients on Adcetris and chemo had better progression-free and overall survival after six years of follow-up compared to those on chemo only.

Takeda's Adcetris has become the first drug recommended for routine NHS use as a treatment for previously untreated ...

From today, adults with advanced Hodgkin lymphoma have access to a new treatment, after we recommended brentuximab vedotin (brand name Adcetris) in combination with other therapies for routine NHS use ...